Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4.

Calder, Jack; Nagelberg, Amy; Luu, Jennifer; Lu, Daniel; Lockwood, William W.

Afiliação

Calder J; Integrative Oncology, British Columbia Cancer, Vancouver, BC, V5Z 1L3, Canada.
Nagelberg A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada.
Luu J; Integrative Oncology, British Columbia Cancer, Vancouver, BC, V5Z 1L3, Canada.
Lu D; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada.
Lockwood WW; Integrative Oncology, British Columbia Cancer, Vancouver, BC, V5Z 1L3, Canada.

Oncogenesis ; 10(3): 27, 2021 Mar 12.

Article em En | MEDLINE | ID: mdl-33712563

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article